News

Filter

1 to 9 of 478 results

Sepsis-specific treatment market set to grow to $354 million in 2021; report

26-03-2015

Following the first sepsis-specific product launch in 2016, the treatment market will expand at a compound…

Antibiotics and Infectious diseasesART-123Asahi Kasei PharmaEli LillyEuropeMarkets & MarketingPharmaceuticalUSAXigris

FDA approval for Emergent BioSolutions’ Anthrasil

25-03-2015

US biopharma company Emergent BioSolutions has received approval from the US Food and Drug Administration…

AnthrasilAntibiotics and Infectious diseasesEmergent BioSolutionsPharmaceuticalRegulationUSA

Antibiotics has an extensive pipeline but first-in-class innovation is low

Antibiotics has an extensive pipeline but first-in-class innovation is low

25-03-2015

Weak financial incentives and high failure rates have discouraged innovation in antibiotics, says a new…

AntibioticsAntibiotics and Infectious diseasesGBI ResearchMotivationResearch

AstraZeneca, GSK and Basilea join public-private project against carbapenem resistance

AstraZeneca, GSK and Basilea join public-private project against carbapenem resistance

25-03-2015

AstraZeneca, GlaxoSmithKline and Basilea are joining a public-private funded project to combat carbapenem…

Antibiotics and Infectious diseasesAstraZenecaBasilea PharmaceuticaGSKPharmaceuticalResearch

Amgen knocked back as US district court will not block Sandoz's Neupogen biosimilar

Amgen knocked back as US district court will not block Sandoz's Neupogen biosimilar

20-03-2015

The US district court has rejected Amgen’s request for a preliminary injunction to block Sandoz’s…

AmgenAntibiotics and Infectious diseasesBiosimilarsFilgrastimLegalNeupogenNovartisOncologySandozUSAZarxio

Positive results for Pfizer’s Prevenar 13 for community acquired pneumonia

Positive results for Pfizer’s Prevenar 13 for community acquired pneumonia

19-03-2015

US pharma giant Pfizer says that positive findings from its Community-Acquired Pneumonia Immunization…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Is big pharma ignoring an impending antibiotic-resistance crisis?

Is big pharma ignoring an impending antibiotic-resistance crisis?

12-03-2015

Despite big Pharma being criticized for not doing enough to tackle an impending antibiotic-resistance…

Antibiotics and Infectious diseasesGlobalPatentsPharmaceuticalResearch

FDA approves Astellas’ new antifungal drug Cresemba

FDA approves Astellas’ new antifungal drug Cresemba

07-03-2015

The US Food and Drug Administration on Friday approved Cresemba (isavuconazonium sulfate), a new antifungal…

Antibiotics and Infectious diseasesAstellas PharmaBasilea PharmaceuticaCresembaPharmaceuticalRegulationUSA

1 to 9 of 478 results

Back to top